Literature DB >> 10824940

Sexually transmitted infections and use of sexual health services among young Australian women: women's health Australia study.

M J Schofield1, V Minichiello, G D Mishra, D Plummer, J Savage.   

Abstract

Our objective was to examine associations between self-reported sexually transmitted infections (STIs) and sociodemographic, lifestyle, health status, health service use and quality of life factors among young Australian women; and their use of family planning and sexual health clinics and associations with health, demographic and psychosocial factors. The study sample comprised 14,762 women aged 18-23 years who participated in the mailed baseline survey for the Australian Longitudinal Study on Women's Health, conducted in 1996. The main outcome measures are self report of ever being diagnosed by a doctor with an STI, including chlamydia, genital herpes, genital warts or other STIs, and use of family planning and sexual health clinics. The self-reported incidence of STI was 1.7% for chlamydia, 1.1% genital herpes, 3.1% genital warts, and 2.1% other STIs. There was a large number of demographic, health behaviour, psychosocial and health service use factors significantly and independently associated with reports of having had each STI. Factors independently associated with use of family planning clinic included unemployment, current smoking, having had a Pap smear less than 2 years ago, not having ancillary health insurance, having consulted a hospital doctor and having higher stress and life events score. Factors independently associated with use of a sexual health clinic included younger age, lower occupation status, being a current or ex-smoker, being a binge drinker, having had a Pap smear, having consulted a hospital doctor, having poorer mental health and having higher life events score. This study reports interesting correlates of having an STI among young Australian women aged 18-23. The longitudinal nature of this study provides the opportunity to explore the long-term health and gynaecological outcomes of having STIs during young adulthood.

Entities:  

Mesh:

Year:  2000        PMID: 10824940     DOI: 10.1177/095646240001100507

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  6 in total

1.  Prevalence of and risk factors for self-reported sexually transmitted infections in Slovenia in 2000.

Authors:  Marta Grgic-Vitek; Igor Svab; Irena Klavs
Journal:  Croat Med J       Date:  2006-10       Impact factor: 1.351

2.  CD4+ cell count and HIV load as predictors of size of anal warts over time in HIV-infected women.

Authors:  Hung N Luu; E Susan Amirian; Wenyaw Chan; R Palmer Beasley; Linda B Piller; Michael E Scheurer
Journal:  J Infect Dis       Date:  2012-01-13       Impact factor: 5.226

Review 3.  Measuring paternal discrepancy and its public health consequences.

Authors:  Mark A Bellis; Karen Hughes; Sara Hughes; John R Ashton
Journal:  J Epidemiol Community Health       Date:  2005-09       Impact factor: 3.710

4.  Combination of qualitative and quantitative methods for developing a new Health Related Quality of Life measure for patients with anogenital warts.

Authors:  Xavier Badia; Jose Antonio Colombo; Nuria Lara; M Angels Llorens; Luis Olmos; Miguel Sainz de los Terreros; Jose Antonio Varela; Juan Jose Vilata
Journal:  Health Qual Life Outcomes       Date:  2005-04-07       Impact factor: 3.186

5.  Smoking, poor nutrition, and sexually transmitted infections associated with pelvic inflammatory disease in remote North Queensland Indigenous communities, 1998-2005.

Authors:  Ming Li; Robyn McDermott
Journal:  BMC Womens Health       Date:  2015-04-01       Impact factor: 2.809

6.  HPV-associated anal lesions in HIV+ patients: long-term results regarding quality of life.

Authors:  Paul Wesselmann; Carolynne Schwarze-Zander; Christoph Boesecke; Jürgen Rockstroh; B Stoffels; Tim O Vilz; Tim R Glowka; J C Kalff; Martin W von Websky
Journal:  Int J Colorectal Dis       Date:  2020-03-26       Impact factor: 2.571

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.